Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What would Mr. Hakim say is the likelihood that Elite will get bought out by a large arrival within the next five years?
Two things I'll say to that. One, cut that prediction in half or more than half. Five years is a very long time to do either. We are at a point where our fundamentals are solid, and we are in a growth stage, as I said earlier. We're not flattening out at $30 million and $40 million. We skip the 40s, went to 50s. And we'll talk in June once I have a little more data, what I expect for the future. But definitely, the year after, we're going to beat that. And the year after, we're going to be that.
So we're at a growth stage. So the fundamentals are looking great, a buyout is looking great. And five years is way too long for that. So I would say either of this will happen in a couple of years.
Last question, let's see, company's futures, what would Mr. Hakim say is the likelihood that Elite will uplift to NASDAQ within the next five years? What would Mr. Hakim say is the likelihood that Elite will get bought out by a large arrival within the next five years?
Two things I'll say to that. One, cut that prediction in half or more than half. Five years is a very long time to do either.
VGTL 0016 WAY $03 +X >> $100m MERGER PENDING >>> READ >>> VGTel Merges With Primary Care Physician Practice acquisition and management company, Strategic Healthcare Alliances, LLC
VGTeL, Inc. is pleased to announce that it has merged with Strategic Healthcare Alliances, LLC.
NEW YORK, NY / ACCESSWIRE / April 10, 2020 / Strategic Healthcare Alliances. LLC is currently doing business in New York City. Strategic Healthcare Alliances, LLC's mission is to acquire primary care physician practices, aggregating a significant number of health plan members assigned to the practices as the member's PCP. They will then negotiate value-based contracts providing the company with global risk contracts, which pay a high percentage of the total premium as revenue, with the health plans who have members assigned to the physicians in the practices acquired. Through the practice management team's broad and deep experience managing primary care practices, significant economies of scale will be achieved through operational activity consolidation.
Strategic Healthcare Alliances, LLC also contains a managed care management team of former health plan executives, CEOs, COOs, CFOs, CMOs, as well as VP level executives. This team will engage with their health plan counterparts, demonstrating significant experience in managing the cost of care, and securing global risk contracts, generating revenues based on a significantly high percentage of the total premium for each member. The initial membership aggregation is expected to result in care management revenues in excess of $100 million, generating a significant additional profit for the company, expected to double the EBDITA of the company with a small additional investment, since the members are already assigned to the primary care physicians of the consolidated group.
Strategic Healthcare Alliances, LLC. plans to implement its mission by leveraging the already existing relationships of its management teams, engaged at the appropriate times, first practice management then managed care management.
Pursuant to the Acquisition and Merger Agreement, a new class of preferred shares will be issued by VGTeL Inc. (OTC PINK:VGTL) as consideration for the acquisition of 96% of Strategic Healthcare Alliances, LLC's issued and outstanding shares. In addition, Mark B. Newbauer will Immediately resign as CEO but remain as on officer and director for a three-month period to assist in the transition.
Kerry A. McDonald will be the new CEO of both VGTeL Inc. (OTC PINK:VGTL) and Strategic Healthcare Alliances, LLC. His impressive resume includes: more than 30 years' healthcare experience at the executive management level including: CEO Magellan Complete Care of Florida, where he planned and executed a financial and operational turnaround, improving from a $47.5 million loss in 2015 to a $45.8 million profit in 2016, just 13 months, becoming profitable in 6 months, he was the start-up CEO of a Medicare Advantage plan, (Liberty Health Advantage); VP of Regional Operations for a managed Medicaid payer in NY and NJ (Americhoice); and the COO of a TennCare PHO, a cost of care management company paid a high percentage of total premium per member (THP). He has extensive experience managing health plan operations including financial services and information support systems. During his career, Kerry led the implementation of a new Amsys claims system and was a leader in the turnaround of an 85k member book-of- business, going from a $30 million loss to a $2.5 million profit, after a 90-day implementation period. Additionally, he conceptualized/implemented a complex rate analysis for UnitedHealth Group that enabled the network management team to re-contract with more than 20k providers which resulted in an annual savings of more than $11M for their New York managed Medicaid plans. Kerry has led the IT implementation of many software system projects unique to health plans, by building teams of people to accomplish these tasks while achieving significant financial results in extremely short time frames.
Kerry holds a BA in finance, and an MS degree in Analytics and Knowledge Management from Notre Dame of Maryland University. He also was a hospital corpsman in the US Navy.
Mark Newbauer, former CEO of VGTeL Inc., states, "this merger will make all stakeholders extremely pleased. Strategic Healthcare Alliance's management teams are second to none which means that they will be a dominant force in the healthcare system management industry."
Kerry McDonald, CEO of VGTeL Inc., excitedly states, "I was impressed with VGTeL's growth which shows the expertise of Mark Newbauer and his management team. I will be bringing the company current in its filings so shareholders can feel the full realization of our rapid growth through the acquisition of Strategic Healthcare Alliances."
Updates will be forthcoming
VGTL: WALL STREET Private Equity Consulting Firm & Morgan Stanley Current Partner, Owned and Ran By Mr. Ray Anam, Has Joined Little Old VGTL As Their President Of Financing & Investors Relations.
Here is VGTL New President Of Financing & Investors Relations Wall Street Firm: https://rayanaminc.com/
NOT Convinced? No Problem, Look at the April 20th, 2020 PR That confirms this is our guy!!!
"In 2017, Mr. Anam founded and started a private equity consulting firm named Ray Anam Inc., located on Wall Street. His firm is an approved alliance partner of Morgan Stanley. Mr. Anam's company's core focus is on specialty finance, corporate lending, wealth management/private banking, commodities, mergers & acquisitions, performing & non-performing notes and real estate acquisition advisory. https://finance.yahoo.com/news/vgtel-inc-york-corporation-otcm-153000896.html
WHY IS A WALL STREET EQUITY INVESTOR & MORGAN STANLEY PARTNER JOINING VGTL? BECAUSE THIS HEALTHCARE MERGER IS BIGGER THAN WE THOUGHT!!! NO WONDER VGTL SAID IN THEIR PR $100 MILLION WILL BE MADE FROM THIS MERGER AND INVESTMENT. THEY HAVE A WALL STREET EXPERIENCED MERGER AND ACQUISITION PROFESSIONAL CRUNCHING THEIR FUTURE NUMBERS!!!
Mr. Ray Anam Extensive Rolodex? Good Lord, I bet this man has all types of Wall Street & Morgan Stanley connections not to mention the pr said he also worked for Bank Of America & Merrill Lynch!!! Look what the pr said about using his "rolodex" to create strong relations that im sure he already have:
"Ray Anam, President of Financing and Investor Relations of VGTeL Inc., states that he is looking forward to this opportunity to contribute to the success of the company. Allowing him to utilize his extensive rolodex as well as to create a strong and responsive investor relations function at VGTeL. He is looking forward to starting with the great team at VGTeL."
Warp 9 to Acquire Profitable E-Commerce Solutions Provider
Published: June 30, 2015 4:00 p.m. ET
Company Signs Definitive Purchase Agreement to Acquire 100% of Colorado-Based E-Commerce Solutions Provider, Indaba Group LLC
SANTA BARBARA, CA, Jun 30, 2015 (Marketwired via COMTEX) -- Warp 9, Inc. (otcqb:WNYN), a leading provider of cloud-based e-commerce and mobile commerce solutions, today announced that it has signed a definitive agreement to acquire 100% of Indaba Group, LLC, (Indaba), a rapidly growing provider of enterprise digital commerce and digital marketing services, based in Denver, Colorado.
This major milestone marks the first transaction in the Company's previously announced growth-by-acquisition strategy. The strategy is aimed at strengthening the company's position and footprint in the industry through the strategic acquisition of profitable solutions providers with strong management teams. With this transaction underway, the Company intends to aggressively seek out other companies to acquire and consolidate into a global provider of cloud-based e-commerce and mobile commerce solutions to help online sellers and leading brands successfully conduct business online.
Indaba focuses on the front-end user interface, development, systems integration and digital marketing of Magento, Oro, and Enterprise Bigcommerce web solutions. It is one of the most trusted names in delivering successful online commerce solutions to retailers and businesses across the country. As part of this transaction, Warp 9 will consolidate its own e-commerce operation with Indaba to create a single solutions provider division, Indaba Group, Inc., which will be a wholly owned subsidiary of Warp 9.
According to data gathered by Statista, B2C e-commerce worldwide sales are estimated to reach $1.92 trillion in 2016. Further reports reveal "In 2018, US mobile retail revenues are expected to amount to 133.5 billion U.S. dollars, up from 42.28 billion U.S. dollars in 2013." The need has never been greater for online merchants to have robust and effective online commerce solutions.
"Acquiring Indaba is a huge win for Warp 9 and a key part of our strategy going forward," said Andrew Van Noy, CEO of Warp 9. "Indaba has the right team, the right customer base, and a shared vision of what we can become together. Indaba founders, Blake Gindi and Ryan Shields, have done an excellent job creating a trusted brand in the Magento, Oro and Bigcommerce industries. Indaba has a strong base of business and reputation in the US, and has a growing foothold in Europe with customer service provided by its UK office. This is a great foundation for us to build a global company together."
Ryan Shields, CEO of Indaba commented, "The Indaba team is incredibly excited to join forces with Warp 9. Since day one, Indaba has sought to work with only the best, including the most talented employees, the most desirable long-term clients and the most highly respected tech firms. It has been our quest to build a company based on the mantra 'Collaborate, Innovate, Grow' and when we met the Warp 9 team we knew we had met the right people to achieve this goal. The merger of our two companies will accelerate our vision to control, influence and guide the entire spectrum of cloud commerce transactions around the globe. Not only do we have a synergy of talents and complementary skills between our teams, but combined together, we will be able to innovate more rapidly, better serve our customers and achieve substantial growth."
Van Noy concluded, "Online commerce will continue to grow significantly over the next decade and it is our corporate goal to become the go-to partner in helping businesses succeed online. We plan to continue aggressively acquiring profitable companies that will strengthen our position as the leading cloud commerce solutions provider in the industry. The acquisition of Indaba is the first step in a very exciting journey."
The closing of the acquisition, as described in the definitive agreement, is subject to Warp 9's satisfactory review of the operations and audit of financial and corporate records of Indaba. The transaction is expected to close by September 2015.
About Warp 9
Warp 9, Inc. is a leading provider of cloud-based e-commerce and mobile commerce solutions. Offering fully managed Software-as-a-Service web and mobile commerce technology, Warp 9 allows customers to focus on their core online businesses, rather than on technical implementations. To learn more about Warp 9, please visit www.warp9inc.com or on Twitter at www.twitter.com/warp9inc, or on Facebook at www.facebook.com/warp9inc. To learn more about Indaba, please visit http://www.indabagroup.com.
Safe Harbor Statement
Matters discussed in this press release contain statements that look forward within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such statements that look forward. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the statements that look forward contained herein, and while expected, there is no guarantee that we will attain the aforementioned anticipated developmental milestones. These statements that look forward are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
Now IF that is the website for the new National Properties Trust then we are ready for blast-off.
Hudson said he WILL acquire MORE marijuana companies and they could very well be placed under the umbrella of the ENTI Real Estate Investment Trust (ENTI) like CWIR &
no longer in. APRU have been.
CWIR JUMPED OVER 2,400% in less than a week! And
not in umbrella anymore. APRU has had a VERY nice run up to much higher levels.
it will be umbrella theory/\ And if ENTI merges with Hudson/Grande they become the HOLDING COMPANY!
And they have even MORE control over: Central Wireless (CWIR), Real American Capital Corporation (US.RLAB.PK),
apru is no longer in umbrella! Apple Rush Company, Inc. (US.APRU.PK),not in port.
umbrella, Oncology Medical, Inc. (US.ONCO.PK), First Intercity Bancsystems, Inc. and every other company that is going to be brought into all of this! And there will be MANY more. And at least a couple of them are MARIJUANA related. This is destined to be a MARIJUANA COMGLOMERATE.
Now if you noticed the PR about the acquisition of CWIR
apru not in no more. & APRU...it was under / no more
ENTI and not CWIR OR
no more under umbrella. APRU. Hmmmmmm....why was that? Answer: because they will all be under NATIONAL PROPERTIES TRUST?
So, ENTI not only has control over ALL OF THE PROPERTY of thoses companies mentioned above...ENTI also has all of the 'rights' that come with being a holding company. That could be VERY big!
And you may also look for: 1. A HUGE merger: 2. A Possible 'Squeeze' according to Cashclan! This is getting very exciting.
SBDG - i talked to Roy Salisbury on the phone (Small Business Development Group Inc. CEO) and he confirmed to me that they are not at all interested in (targeting) Day Traders, Short Term Flippers or P&D Promos of any kind...fwiw
SBDG Share Structure -
Market Value1 $6,641,036 a/o Feb 24, 2014 Shares Outstanding 1,302,164 a/o Jan 13, 2014 Float 152,793 a/o Jan 13, 2014 Authorized Shares 15,000,000 a/o Sep 30, 2013
SBDG / interesting read from Roy's (CEO of Small Business Development Group Inc.) blog page -
first of all i admit, i am only now beginning to understand what it is that they're even doing over there Lol.
maybe Roy Salisbury is actually on to something here!
investors in this must all be gagged Lol! they should all be here holding Q&A Sessions so we would know and understand exactly what the heck Small Business Development Group Inc. really is! Hha
..benefit from our public status...merge your Company with an SBDG Special Purpose Vehicle (SPV).
SBDG is specifically seeking profitable companies in which their current owners want to maximize the value of their assets and are willing to enter into a structured buyout while remaining with the company and helping SBDG grow. This increases the value proposition for all concerned.
SBDG mitigates risk for both the seller and for SBDG by structuring a “Soft Leverage Buy-Out”...based on an exchange of securities tied to a short-term cash-out schedule as a down payment, and completed over a period of 24 to 36 months.
The seller benefits from SBDG’s status as a public company and thereby achieves greater value and liquidity. SBDG already has substantial revenue and financial strength that will continue to grow throughout and because of this transaction, creating additional value for both parties.
..it is easier for SBDG to finance something it already owns, based on the enhanced value it gains by being part of a public company...as we invest in your company, we gain added value in the form of a Return on Investment (ROI) from the value above your premium. And when the company is either sold or goes public, SBDG will benefit from that transaction.
The Benefits of Being Public Without Being Public
Roy Salisbury - Thursday , February 20 , 2014
How to Take Advantage of the Private-to-Public Arbitrage
Are you looking for growth capital, liquidity, or maybe a timed retirement from your private company? If so, the following information may be of interest to you.
Owners and managers of small businesses are usually not well-equipped for the public market, and therefore should not go public until they are ready and well-positioned to do so. Under our model, your company remains private until you and the Company are ready for the public rodeo! Small Business Development Group, Inc. (SBDG) has a business model that helps you and your Company benefit from our public status without burdening you with the cost and risk associated with being a public company.
Our model is simple, but is a little unorthodox for many, and it will not work for everyone. You merge your Company with an SBDG Special Purpose Vehicle (SPV). SBDG will own 80% of that SPV and you will own 20%; but you will own 100% of a specially-designed preferred stock that protects you with an agreed-upon value position. Over an agreed-upon schedule, you can liquidate your position for cash, registered stock and senior debt, or, when ready, take your company public and raise additional capital to fund growth, creating liquidity for all of your stakeholders.
Small Business Development Group, Inc. (SBDG) acquires private companies having enterprise values of $2 to $20 million for its portfolio. SBDG is specifically seeking profitable companies in which their current owners want to maximize the value of their assets and are willing to enter into a structured buyout while remaining with the company and helping SBDG grow. This increases the value proposition for all concerned.
SBDG mitigates risk for both the seller and for SBDG by structuring a “Soft Leverage Buy-Out”. The seller and SBDG agree on a valuation, then they close the transaction based on an exchange of securities tied to a short-term cash-out schedule as a down payment, and completed over a period of 24 to 36 months.
This process protects the seller, who is required to continue running the Company for an agreed period of time. In many cases, this process allows the seller to receive a greater value for his asset (the Company) than would be possible otherwise, and offers definable upside potential as the Company grows. The seller benefits from SBDG’s status as a public company and thereby achieves greater value and liquidity. SBDG already has substantial revenue and financial strength that will continue to grow throughout and because of this transaction, creating additional value for both parties.
Why the elaborate strategy? Simply stated, it is easier for SBDG to finance something it already owns, based on the enhanced value it gains by being part of a public company. SBDG has a team of professionals who are dedicated to the success of the transaction to insure performance of all stakeholders. The seller takes no more risk than they currently have as operators of a private business; furthermore, you remain in complete control while receiving your payout.
In many respects, you the seller are getting the best of both worlds. You will receive a premium on value and have a number of sound exit strategies, both short and long term. During the term of the transaction, SBDG will use its public status to raise additional capital to grow the firm, thereby creating added value.
What is in it for SBDG? We get to consolidate your financials with ours, creating greater share-value and liquidity. And as we invest in your company, we gain added value in the form of a Return on Investment (ROI) from the value above your premium. And when the company is either sold or goes public, SBDG will benefit from that transaction.
If you are intrigued by this strategy, and if you think this might help you make the financially-beneficial transition you seek, then we should talk. I’d like the opportunity to discuss this program further with you and your client.
Wonder what happened to the stock "guru' choi boy? lollol. I heard that he is flipping burgers at Teddy's Bigger Burgers on Oahu. Should hold what you recommend, and you would do better than flipping. At least you are flipping something, right? Flip them burgers choi boy ! Can always start now, and make a change. A sequence of correct decisions is all that is needed, but you must remain focused on making the correct decision, and not try pleasing other people. Try it. It WILL work choi. A series of correct decisions. Simple, but hard. Hard, but simple. You choose your own path "Brah". Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee!!!!!
so far all of your picks have failed,as you dumped them on un suspection ones,you frontloaded and said pspw going to 13.00 sttn going to dollars/apii going to dollars/gtgp no financials needed...going to dollars,everything backtraces as they aren't real companies backed by competence or financial strength...you pumped them,the sad part is everybody laughs at you in pm even from kimpsheehead stock group...you never go even to say hello...your reputation is in shambles,your dd never was yours but repackaged dd with a twist,im trying to help you and leave you with some sort of self esteem but don't know how,you just blew it and should change your user name and start fresh so you can get in another pump before its realized ...its him again,go have a good cry,admit your sins and comeback and be a follower not a leader,you led too many to financial ruin by your badness but not me,i was too smart for you and didn't give you any more of my $$$ your a thief and scammer but you don't have to be if you don't want to be...please take all this constructively and rebuild your brand...and finally get a good reputation if it isn't too late. also your chronies looking for security leaks in the might 888...lol why,nobody makes money there so its not like it should matter,many belong to better groups with a leader with true backbone/grit
its best not to pump promising inside info like your other stock picks you dumped on everybody who ever trusted you...why oh why?? 888 group is criminal...not the victims though
im hoping that gtgp gets going,the stocks pspw/apii/sttn and that hepititus pump/dumps made you lots but cost shareholders dearly and you kept pumping ...while dumping...you were pumping pspw over 2.00 going to 13.00 pps and abandoned everybody like at gtgp,you said youl make it up to us but...i think you need more money,so youl lure in more of us,you have some that still support you but i dont know why,its not your fault it went to the grays but its your fault you lured ones and dumped it over $1.00 pps...
BE MG .15x.20 RM coming.imo 90% held by insiders, billionaire dealer owns most. No longer a shell so RM is the next step. Going to be 1.00+ Maybe even 2.00 in my opinion.
No GTGP RFP listed, even when squinting hard. Oh, must be an RFP through ARRA funds? Sorry. US Gov't contracts have full disclosure and transparency. They, ARRA funds, are not secretly allocated either. In fact, ARRA funds have much more oversight.
sign me up! here is your post dipshit Only get one post a day there from laughing at you two morons...but I'll correct my bad mistake..Makes me look pretty bad making a wrong post ..when
choifunds
Sunday, December 09, 2012 2:35:23 AM
Re: gone4ever post# 82446
Post # of 85991
And that's going to be obviously huge for us. We'll find out this month on whether if they made any changes from the proposals.
GTGP can capture a whole lot of contracts from these cement kilns that may have the ability to produce billions of dollars in revenue for us next year... If this mandate falls through in our favor, then the world will be our oyster...
Hey Buc, I would like to hear your take on RVPL, still trading around .10 but we already have two contracts for right about $2,000,000,000
I can't figure out why most people over look this company but soon most will have to chase, I'm only telling you about this because I followed you and choi to gtgp and I just want to share the favor with you both
gangnam style...,if this isnt a flop like pspw/sttn/and that hep stock p/d then it will be fine but the great dd and thanks dosent go north of the 38th
CTIX DD - A Primer updated FOLLOW THE MONEY Last Q 3/31/2012 10M preferred authorized, 0 issued 94M os 44M float 94k cash 7.2M total liabilities (2.6M payroll, $2,022,264 officer loan)
SO WHAT IS THE BIG DEAL?
Quote: -------------------------------------------------------------------------------- KevetrinTM a compound that activates p53 "Guardian Angel of the Human Genome". P53 activates proteins required to repair DNA. In more than 50 percent of all human carcinomas, p53 is limited in its anti-tumor activities by mutations in the protein itself. Currently, there are greater than 10 million people with tumors that contain inactivated p53, while a similar number have tumors in which the p53 pathway is partially abrogated by inactivation of other signaling components. This has left cancer researchers with the grand challenge of searching for therapies that could restore the protein’s protective function, which Kevetrin appears to be doing the majority of the time. --------------------------------------------------------------------------------
Quote: -------------------------------------------------------------------------------- In the laboratory, Kevetrin activates p53, a tumor suppressor protein that has an important role in protecting the body. p53 functions by activating proteins that repair DNA and kill cells that have genetic mutations such as in cancers. Research experiments showed that when cancer cells were treated with Kevetrin, it activated p53 which induced p21, a protein that inhibits cancer cell growth. p53 also induced PUMA (p53 up-regulated modulator of apoptosis), a protein that causes tumor cell death. Because of these activities, slowing cancer cell growth and causing cancer cell death, Kevetrin may help to treat tumors. --------------------------------------------------------------------------------
Quote: -------------------------------------------------------------------------------- Cellceutix consultant Dr. Sylvia Holden commented, "I have been researching new drugs for nearly 30 years. Cellceutix is now a true pioneer in oncology discovery with this very special compound, Kevetrin. The Mechanism of Action of Kevetrin™, impacting both wild and mutant types of p53 to induce apoptosis and cell cycle arrest through multiple pathways while being well-tolerated, is what sets it apart from other chemotherapies today. Rather than being a traditional drug that targets and attempts to seek and destroy cancer cells independently, Kevetrin™ revitalizes p53 so that the body's natural defense system eliminates the tumor on its own. As a stand-alone or combination front-line therapy, the magnitude of the potential of Kevetrin™ is simply unparalleled by anything that I have ever seen in the laboratory before." --------------------------------------------------------------------------------
Pipeline, from website(updated)
Kevetrin Cancer Phase 1 Prurisol Psoriasis Phase 2/3 505(b)(2) KM 391 Autism Preclinical KM 227 Arthritis Preclinical KM 278 Arthritis/Asthma Preclinical KM 3174 Cancer Early R&D KM 362 MS/ALS/Park Early R&D KM 732 Hypertensive emergency Early R&D
*** Cellceutix filed Phase 1 for Kevetrin @ ClinicalTrials.gov.
THE SHORT VERSION:
Quote: -------------------------------------------------------------------------------- To determine the maximum tolerated dose (MTD) of Kevetrin. To determine the dose limiting toxicities (DLT) of Kevetrin. To establish a safe dose level of Kevetrin that can be used for future studies.
The secondary objectives are to determine the following:
The pharmacokinetics of Kevetrin in humans. Observe for evidence of antitumor activity following administration of Kevetrin. If there is a pharmacodynamic relationship between the plasma concentrations of Kevetrin and a clinical/cellular effect. If Kevetrin induces changes in the biomarker p21 in peripheral blood lymphocytes.
"Throughout my career, I have evaluated and seen many new drug candidates go from start to finish through the regulatory pathway and I am extremely optimistic and excited about the potential of Kevetrin™ because of our data collected during extensive studies and the p53 connection as the Mechanism of Action. I'm not aware of any other anti-cancer compound at this stage of development that could have such a dramatic impact in the field of oncology. Dana-Farber is one of the few hospitals in the world that collects data 'mapping' the human genome as related to tumor profiling and the information that will be collected from our clinical trials of Kevetrin™ could prove an invaluable asset to those suffering from cancer and to Cellceutix." commented Dr. Krishna Menon, Chief Scientific Officer at Cellceutix.
*** 8/6/2012 Dana-Farber Cancer Institute received Kevetrin™, the Company's flagship anti-cancer drug, for the commencement of hospital funded clinical trials.
*** 9/24/2012- Cellceutix expects the process of activation, recruitment, enrolling and first dosing to take approximately 3 weeks.
*Prurisol™ (psoriasis) the path to phase 2:
* 1/3/2012--The Company will be interacting with the FDA regarding obtaining 505(b)(2) designation for KM-133 (psoriasis) so it may be advanced immediately to Phase II clinical trials.
* 6/13/2012--Cellceutix is extremely pleased to announce that the FDA has informed the Company that a 505(b)(2) application would be an acceptable approach for Prurisol™ (psoriasis)
* 7/16/2012--"We have conducted multiple meetings with companies to manufacture Prurisol™ and are aligning our strategies to advance the drug candidate into human trials as expeditiously and efficiently as possible"
* 9/4/2012--"Cellceutrix announces the selection of Dr. Reddy's Laboratories Ltd., a New York Stock Exchange-listed company traded under the ticker "RDY," for the manufacturing of Prurisol™, the Company's new drug candidate for the treatment of psoriasis.
* Kevetrin™ Leukemia the path to Phase 1
* 9/10/2012--Cellceutix in discussions with top 10 European University wishing to fund clinical trials on Kevetrin™
This Board is to list, any type of Buyouts, Acquisitions & Mergers, from micro's to big caps... It's that simple... The key goal here is to dig into these terms, get in early, and hopefully make some nice profit...
#3) WSGF potential 50 bagger or more.... End of month acquisition update will be announced... (sttn and tdlpq good ones... and tstrq for super lotto;checking out mrps)
~Gotusucka
DIII Name change and new management expecting new filings announcing the change any day now. TVCE Mark Anthony shell trading in triple zero's. BMSPF New name, new business plan. Recent acquisition puts company in line to produce almost $300 million in revenue per year.And of course WSGF!
~pumpnass
IDMV STDR are two merger plays i'm holding patience will pay off big time
~doebop----->>>> 1---> STTN 2---> UNVC 3---> TOFS 4---> SYRX 5---> DTTO (more later) Of couse I like PSPW, GTGP, and PRGJ as well I have another hidden gym but it won't be announced until sometime in August:
A friendly B.A.M! competition amongst the B.A.M BoyZ will commence shortly achieving Top Dog Status for the week and/or month... Also players here who tally up the most amount of %'s of their 3 picks(our picks) will win a Month Free Subscription to IHUB... More to come players...- B.A.M!
Disclaimer:
B.A.M! - (((Buyouts, Acquisitions & Mergers))), and it's moderators are not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. We may hold positions in the stocks, currencies or industries discussed here.
You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. We assume no responsibility or liability for your trading and investment results. Factual statements on the website are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by us are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you.
In addition, the indicators, strategies, columns, articles and all other features of our products. (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice.
Examples presented on our website are for informational purposes only and are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments.
You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
News 
Market Data 
Discover 
